These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 5682033

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Combined fibrinolytic-clearing treatment in obliterative endareteritis in the aged patient].
    Baldoni E.
    G Gerontol; 1967 Dec; 15(12):1477-89. PubMed ID: 5618944
    [No Abstract] [Full Text] [Related]

  • 4. [The treatment of vascular diseases with a magnesium containing drug (Progresin)].
    Straube G.
    Z Allgemeinmed; 1975 Mar 27; 51(9):450-5. PubMed ID: 1163068
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Medical treatment of acute arterial obliteration in the limbs].
    Serradimigni A, Bory M, Poggi L, Audier M.
    Rev Atheroscler (Paris); 1968 Mar 27; 10(2):3-8. PubMed ID: 5759950
    [No Abstract] [Full Text] [Related]

  • 8. Vasodilator drugs in the treatment of peripheral arterial insufficiency.
    Hansteen V, Lorentsen E.
    Acta Med Scand Suppl; 1974 Mar 27; 556():3-62. PubMed ID: 4366049
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment of degenerative diseases of the retina with progresin retard].
    Schaaf G.
    Munch Med Wochenschr; 1970 Mar 06; 112(10):433-6. PubMed ID: 5537870
    [No Abstract] [Full Text] [Related]

  • 10. [Therapy of cerebral sclerosis from the viewpoint of the practitioner].
    Orth H.
    Z Allgemeinmed; 1970 May 31; 46(15):800-5. PubMed ID: 5522943
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Progress surveillance of limb artery occlusions].
    Bollinger A, Lüthy E.
    Schweiz Med Wochenschr; 1966 Aug 27; 96(34):1094-8. PubMed ID: 5985858
    [No Abstract] [Full Text] [Related]

  • 14. [Intra-arterial heparin and vasodilator injections at the initial phase of acute arterial obliteration in the extremities].
    Bergogne C.
    Rev Atheroscler (Paris); 1968 Aug 27; 10(2):11-3. PubMed ID: 4997999
    [No Abstract] [Full Text] [Related]

  • 15. [Peripheral arteriosclerosis obliterans].
    Langer B.
    Rev Paul Med; 1990 Aug 27; 108(5):195-9. PubMed ID: 2103059
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A clinical evaluation of the 'vasculator' in the treatment of peripheral vascular disease.
    Hartfall WG, Woodcock JP, Ellis FG, Gosling RG.
    Guys Hosp Rep; 1972 Aug 27; 121(1):37-44. PubMed ID: 4665890
    [No Abstract] [Full Text] [Related]

  • 19. Long-term effect of anticoagulants in obliterative arterial disease of the legs.
    Tillgren C, Lund F.
    Scand J Clin Lab Invest Suppl; 1967 Aug 27; 99():184-6. PubMed ID: 6056920
    [No Abstract] [Full Text] [Related]

  • 20. [The vasoactivogram in the treatment of peripheral arteriopathies].
    Romeo S, Spinella G, Sciacchitanto D.
    Angiologia; 1975 Aug 27; 27(1):7-25. PubMed ID: 1111377
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.